I was an undergraduate at Queen’s University Belfast. After obtaining my MRCOG I joined the Reproductive Medicine Team at Imperial College London. I came to Oxford in 1997 as a Sub-Specialist trainee in Reproductive Medicine and upon completion joined the academic staff of NDOG as a Senior Fellow and Honorary Consultant in Reproductive Medicine and Surgery. From 1999 until 2012 I was Director of the Sub-Specialist training program in Reproductive Medicine in Oxford. I was Medical Director and Lead Consultant in the Oxford Fertility Unit from 1999 until 2012. In 2011 I initiated and was one of the Foundering Partners of an IVF clinic network (Reproductive Partnership) which is now the largest in the UK. Working with Stephen Kennedy I facilitated the development of the now very successful MSC course in Reproductive Medicine which is closely linked to the IVF facility. From 1999 building on collaboration with Leuven University I developed the Endometriosis surgical service in Oxford to eventually become a national referral centre. I was appointed Associated Professor in 2014.
Other activities have included:
- 1997-2000: USAID / WHO Women and Children programme in Ukraine and Russia.
- HFEA Appeal Committee Member ( 2009 – 2012)
MB BCh BAO MPhil FRCOG
- Consultant and Sub-Specialist in Reproductive Medicine and Surgery
My research has been mostly based in Reproductive Medicine and Endometriosis. My current area of research interest are in Ovarian tissue cryopreservation for pre-pubertal and adolescent girls as well as supporting the Endometriosis research activity now lead by Christian Becker.
Total levels, localization patterns, and proportions of sperm exhibiting phospholipase C zeta are significantly correlated with fertilization rates after intracytoplasmic sperm injection.
Yelumalai S. et al, (2015), Fertil Steril, 104, 561 - 8.e4
Evaluation of the use and handling of three different pen systems considered for in vitro fertilization treatment.
Imthurn B. et al, (2014), Expert Opin Drug Deliv, 11, 1859 - 1864
BLASTOCYST EXPANSION AND INNER CELL MASS GRADES ARE ASSOCIATED WITH CLINICAL PREGNANCY IN FRESH SINGLE TRANSFERS.
Subira J. et al, (2014), FERTILITY AND STERILITY, 102, E63 - E63
The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
Fatum M. et al, (2013), Hum Fertil (Camb), 16, 235 - 240
RESCUE IN-VITRO MATURATION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS OVERRESPONDING/UNDERRESPONDING TO OVARIAN STIMULATION IN IN-VITRO FERTILIZATION TREATMENT: IS IT A VIABLE OPTION?
Fatum M. et al, (2013), FERTILITY AND STERILITY, 100, S271 - S271